These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


477 related items for PubMed ID: 19339089

  • 1. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.
    Scharpé J, Peetermans WE, Vanwalleghem J, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Evenepoel P.
    Am J Kidney Dis; 2009 Jul; 54(1):77-85. PubMed ID: 19339089
    [Abstract] [Full Text] [Related]

  • 2. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T.
    Scand J Urol Nephrol; 2003 Jul; 37(1):71-6. PubMed ID: 12745749
    [Abstract] [Full Text] [Related]

  • 3. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
    Lertdumrongluk P, Changsirikulchai S, Limkunakul C, Prachukthum P, Punpiput P, Buppanharun R, Chotpitayasunondh C.
    Vaccine; 2012 Feb 01; 30(6):1108-14. PubMed ID: 22178515
    [Abstract] [Full Text] [Related]

  • 4. Active influenza immunization in hemodialysis patients: comparison between single-dose and booster vaccination.
    Song JY, Cheong HJ, Ha SH, Kee SY, Jeong HW, Kim WJ.
    Am J Nephrol; 2006 Feb 01; 26(2):206-11. PubMed ID: 16699258
    [Abstract] [Full Text] [Related]

  • 5. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Rheumatology (Oxford); 2009 Oct 01; 48(10):1294-9. PubMed ID: 19692457
    [Abstract] [Full Text] [Related]

  • 6. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ, Gussekloo J, Remmerswaal JE, Remarque EJ, Kroes AC.
    J Med Virol; 2009 May 01; 81(5):908-14. PubMed ID: 19319953
    [Abstract] [Full Text] [Related]

  • 7. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
    Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL, American Lung Association Asthma Clinical Research Centers.
    J Allergy Clin Immunol; 2004 Apr 01; 113(4):717-24. PubMed ID: 15100679
    [Abstract] [Full Text] [Related]

  • 8. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2007 Sep 17; 25(37-38):6692-8. PubMed ID: 17697730
    [Abstract] [Full Text] [Related]

  • 9. High ferritin, but not hepcidin, is associated with a poor immune response to an influenza vaccine in hemodialysis patients.
    Eiselt J, Kielberger L, Sedlácková T, Racek J, Pazdiora P.
    Nephron Clin Pract; 2010 Sep 17; 115(2):c147-53. PubMed ID: 20407274
    [Abstract] [Full Text] [Related]

  • 10. Lack of effect of a booster dose of influenza vaccine in hemodialysis patients.
    Tanzi E, Amendola A, Pariani E, Zappa A, Colzani D, Logias F, Perego A, Zanetti AR.
    J Med Virol; 2007 Aug 17; 79(8):1176-9. PubMed ID: 17596830
    [Abstract] [Full Text] [Related]

  • 11. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.
    Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ.
    J Infect Dis; 2009 Jul 15; 200(2):172-80. PubMed ID: 19508159
    [Abstract] [Full Text] [Related]

  • 12. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
    Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN.
    Clin Gastroenterol Hepatol; 2007 Jul 15; 5(7):851-6. PubMed ID: 17544875
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults.
    Chi RC, Rock MT, Neuzil KM.
    Clin Infect Dis; 2010 May 15; 50(10):1331-8. PubMed ID: 20377407
    [Abstract] [Full Text] [Related]

  • 14. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of the trivalent influenza vaccination in Thai patients with hemodialysis or kidney transplant compared with healthy volunteers.
    Krairittichai U, Chittaganpitch M.
    J Med Assoc Thai; 2013 Mar 27; 96 Suppl 3():S1-7. PubMed ID: 23682516
    [Abstract] [Full Text] [Related]

  • 16. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus AD.
    Vaccine; 2004 Jun 02; 22(17-18):2199-201. PubMed ID: 15149777
    [Abstract] [Full Text] [Related]

  • 17. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.
    Iorio AM, Camilloni B, Basileo M, Neri M, Lepri E, Spighi M.
    Gerontology; 2007 Jun 02; 53(6):411-8. PubMed ID: 17975317
    [Abstract] [Full Text] [Related]

  • 18. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, Weber F, Saville M.
    J Infect Dis; 2008 Sep 01; 198(5):650-8. PubMed ID: 18652550
    [Abstract] [Full Text] [Related]

  • 19. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
    Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P.
    Vaccine; 2009 Dec 09; 27(52):7304-12. PubMed ID: 19849996
    [Abstract] [Full Text] [Related]

  • 20. Flu: effect of vaccine in elderly care home residents: a randomized trial.
    Gaughran F, Walwyn R, Lambkin-Williams R, Whelan P, Chatterton K, Oxford J, Macdonald A, Flu-Effect of Vaccine in Elderly Residents Trial team.
    J Am Geriatr Soc; 2007 Dec 09; 55(12):1912-20. PubMed ID: 18081669
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.